Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 11.65% is in line with its 5-year average of 12.62%, near the low end of its 5-year range (5.31%–28.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.19% above its 12-month average of 10.29%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 11.65%.
RETURN ON EQUITY (ROE)
11.65%
RETURN ON EQUITY (ROE) AVG TTM
10.29%
RETURN ON EQUITY (ROE) AVG 3Y
8.39%
RETURN ON EQUITY (ROE) AVG 5Y
12.62%
RETURN ON EQUITY (ROE) AVG 10Y
13.17%
RETURN ON EQUITY (ROE) AVG 15Y
14.76%
RETURN ON EQUITY (ROE) AVG 20Y
17.22%
CURRENT VS TTM AVG
+13.19%
CURRENT VS 3Y AVG
+38.82%
CURRENT VS 5Y AVG
-7.72%
CURRENT VS 10Y AVG
-11.54%
CURRENT VS 15Y AVG
-21.10%
CURRENT VS 20Y AVG
-32.39%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-10.49%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$25.55B
Return on Equity (ROE)
11.65%
TTM Avg
10.29%
3Y Avg
8.39%
5Y Avg
12.62%
Market Cap
$25.94B
Return on Equity (ROE)
14.13%
TTM Avg
13.34%
3Y Avg
14.07%
5Y Avg
18.07%
Market Cap
$26.14B
Return on Equity (ROE)
7062.40%
TTM Avg
-2178.82%
3Y Avg
-341.14%
5Y Avg
-117.12%
Market Cap
$24.62B
Return on Equity (ROE)
25.41%
TTM Avg
12.92%
3Y Avg
11.29%
5Y Avg
9.83%
Market Cap
$24.37B
Return on Equity (ROE)
18.89%
TTM Avg
16.95%
3Y Avg
19.08%
5Y Avg
20.56%
Market Cap
$24.30B
Return on Equity (ROE)
-9.62%
TTM Avg
-4.55%
3Y Avg
10.63%
5Y Avg
21.70%
Market Cap
$28.88B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$21.10B
Return on Equity (ROE)
20.48%
TTM Avg
18.68%
3Y Avg
17.25%
5Y Avg
16.03%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.55B | 11.65% | 10.29% | 8.39% | 12.62% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | 14.13% | 13.34% | 14.07% | 18.07% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.14B | 7062.40% | -2178.82% | -341.14% | -117.12% |
| Incyte Corporation (INCY)vs › | $24.62B | 25.41% | 12.92% | 11.29% | 9.83% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | 18.89% | 16.95% | 19.08% | 20.56% |
| BioNTech SE (BNTX)vs › | $24.30B | -9.62% | -4.55% | 10.63% | 21.70% |
| Medline Inc. (MDLN)vs › | $27.51B | 5.97% | 9.02% | 4.86% | 4.86% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.88B | 14.51% | 21.84% | 21.53% | 32.27% |
| United Therapeutics Corporation (UTHR)vs › | $21.10B | 20.48% | 18.68% | 17.25% | 16.03% |
| Waters Corporation (WAT)vs › | $30.54B | 1.09% | 29.98% | 64.02% | 111.55% |
ROE
11.6%
ROA
5.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 11.65% |
| 2026-03-31 | 10.79% |
| 2025-12-31 | 10.17% |
| 2025-09-30 | 9.83% |
| 2025-06-30 | 9.01% |
| 2025-03-31 | 8.80% |
| 2024-12-31 | 9.26% |
| 2024-09-30 | 5.33% |
| 2024-06-30 | 5.61% |
| 2024-03-31 | 5.44% |
| 2023-12-31 | 5.31% |
| 2023-09-30 | 8.40% |
| 2023-06-30 | 9.46% |
| 2023-03-31 | 9.67% |
| 2022-12-31 | 12.67% |
| 2022-09-30 | 17.40% |
| 2022-06-30 | 19.14% |
| 2022-03-31 | 19.58% |
| 2021-12-31 | 23.14% |
| 2021-09-30 | 26.25% |
| 2021-06-30 | 28.10% |
| 2021-03-31 | 26.37% |
| 2020-12-31 | 16.49% |
| 2020-09-30 | 10.25% |
| 2020-06-30 | 4.93% |
| 2020-03-31 | 4.57% |
| 2019-12-31 | 10.89% |
| 2019-09-30 | 10.44% |
| 2019-06-30 | 12.94% |
| 2019-03-31 | 13.61% |
| 2018-12-31 | 13.71% |
| 2018-09-30 | 20.76% |
| 2018-06-30 | 18.39% |
| 2018-03-31 | 17.89% |
| 2017-12-31 | 18.64% |
| 2017-09-30 | 12.17% |
| 2017-06-30 | 12.67% |
| 2017-03-31 | 13.35% |
| 2016-12-31 | 13.12% |
| 2016-09-30 | 11.81% |
| 2016-06-30 | 11.77% |
| 2016-03-31 | 11.53% |
| 2015-12-31 | 8.82% |
| 2015-09-30 | 8.99% |
| 2015-06-30 | 8.93% |
| 2015-03-31 | 8.83% |
| 2014-12-31 | 18.12% |
| 2014-09-30 | 18.69% |
| 2014-06-30 | 19.91% |
| 2014-03-31 | 21.57% |
| 2013-12-31 | 23.03% |
| 2013-09-30 | 22.12% |
| 2013-06-30 | 21.30% |
| 2013-03-31 | 20.47% |
| 2012-12-31 | 21.46% |
| 2012-09-30 | 22.02% |
| 2012-06-30 | 22.21% |
| 2012-03-31 | 21.34% |
| 2011-12-31 | 20.76% |
| 2011-09-30 | 20.29% |
| 2011-06-30 | 20.23% |
| 2011-03-31 | 23.02% |
| 2010-12-31 | 22.63% |
| 2010-09-30 | 25.07% |
| 2010-06-30 | 25.37% |
| 2010-03-31 | 25.31% |
| 2009-12-31 | 25.94% |
| 2009-09-30 | 25.71% |
| 2009-06-30 | 24.99% |
| 2009-03-31 | 25.69% |
| 2008-12-31 | 27.51% |
| 2008-09-30 | 27.76% |
| 2008-06-30 | 25.54% |
| 2008-03-31 | 28.46% |
| 2007-12-31 | 27.64% |
| 2007-09-30 | 23.41% |
| 2007-08-01 | 24.12% |
| 2007-03-31 | 25.30% |
| 2006-12-31 | 21.83% |
| 2006-09-30 | 19.43% |
| 2006-06-30 | 19.99% |
| 2006-03-31 | 20.95% |
| 2005-12-31 | 20.48% |
| 2005-09-30 | 17.61% |
| 2005-06-30 | 17.94% |
| 2005-03-31 | 18.58% |
| 2004-12-31 | 18.16% |
| 2004-09-30 | 18.02% |
| 2004-06-30 | 18.02% |
| 2004-03-31 | 17.33% |
| 2003-12-31 | 16.93% |
| 2003-09-30 | 16.63% |
| 2003-06-30 | 15.47% |
